Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Regenerative Medicine
  4. Postinjury Induction of Activated ErbB2 Selectively Hyperactivates Denervated Schwann Cells and Promotes Robust Dorsal Root Axon Regeneration

Postinjury Induction of Activated ErbB2 Selectively Hyperactivates Denervated Schwann Cells and Promotes Robust Dorsal Root Axon Regeneration

The Journal of Neuroscience, 2017 · DOI: 10.1523/JNEUROSCI.0903-17.2017 · Published: November 8, 2017

Regenerative MedicineNeurology

Simple Explanation

Following nerve injury, Schwann cells change into a repair state that helps axons regenerate. This study explores a way to boost the repair ability of these cells to improve axon regeneration, particularly in dorsal root axons. The researchers used a special line of mice to activate a protein called ErbB2 specifically in Schwann cells after nerve damage. They found that activating ErbB2 increased the number and activity of Schwann cells, leading to more axon growth. Additionally, a growth factor called GDNF helped these activated Schwann cells guide axons to penetrate into the spinal cord, suggesting a combined approach for better nerve repair.

Study Duration
2 weeks
Participants
Male and female mice of a doxycycline-inducible transgenic line
Evidence Level
Not specified

Key Findings

  • 1
    Post-injury induction of caErbB2 in SCs selectively hyperactivates denervated, but not innervated, SCs, increasing their proliferation and prolonging their dedifferentiation.
  • 2
    caErbB2 induction in SCs promotes DR regeneration through a transection injury, improving axon penetration and extension along the root.
  • 3
    Intraspinal GDNF treatment drives robust intraspinal penetration of SCs and axons across the DREZ in caErbB2-induced animals.

Research Summary

This study investigates the effects of post-injury ErbB2 activation in Schwann cells (SCs) on dorsal root (DR) axon regeneration using a doxycycline-inducible transgenic mouse line. The results demonstrate that selective activation of ErbB2 in denervated SCs enhances their repair capacity and promotes robust DR axon regeneration, without causing significant off-target effects in intact nerves. Furthermore, combining ErbB2 activation with glial cell line-derived neurotrophic factor (GDNF) significantly improves the penetration of DR axons into the spinal cord, indicating a potential therapeutic strategy for nerve repair.

Practical Implications

Therapeutic Target

ErbB2 is identified as a potential therapeutic target for enhancing nerve regeneration.

Spatiotemporal Regulation

Spatiotemporal regulation of ErbB2 activation is essential to avoid prolonged, excessive activation for therapeutic application.

Clinical Applications

SC-selective delivery of caErbB2 could dramatically accelerate peripheral nerve regeneration and reactivate chronically denervated SCs.

Study Limitations

  • 1
    Study conducted on mice, results may not directly translate to humans.
  • 2
    Limited study duration of 2 weeks post-injury.
  • 3
    Heterozygous caErbB2 cTg mice were used, and caErbB2 was induced only for 2 weeks to avoid tumorigenic ErbB2 activation.

Your Feedback

Was this summary helpful?

Back to Regenerative Medicine